Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
Moshe Phillip, Revital Nimri, Richard M. Bergenstal, et al.
Endocrine Reviews (2022) Vol. 44, Iss. 2, pp. 254-280
Open Access | Times Cited: 228

Showing 1-25 of 228 citing articles:

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S158-S178
Open Access | Times Cited: 282
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S77-S110
Open Access | Times Cited: 133
7. Diabetes Technology: Standards of Care in Diabetes—2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S126-S144
Open Access | Times Cited: 132
Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes
Tara Lee, Corinne Collett, Simon Bergford, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 17, pp. 1566-1578
Open Access | Times Cited: 95
Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes
Jennifer McVean, Gregory P. Forlenza, Roy W. Beck, et al.
JAMA (2023) Vol. 329, Iss. 12, pp. 980-980
Open Access | Times Cited: 52
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, et al.
Diabetes Care (2024) Vol. 48, Iss. Supplement_1, pp. S181-S206
Closed Access | Times Cited: 36
Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial
Katrien Benhalima, Kaat Beunen, Nancy Van Wilder, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 6, pp. 390-403
Closed Access | Times Cited: 35
Artificial intelligence for diabetes care: current and future prospects
Bin Sheng, Krithi Pushpanathan, Zhouyu Guan, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 8, pp. 569-595
Closed Access | Times Cited: 24
New advances in type 1 diabetes
Savitha Subramanian, Farah Khan, Irl B. Hirsch
BMJ (2024), pp. e075681-e075681
Open Access | Times Cited: 22
7. Diabetes Technology: Standards of Care in Diabetes—2025
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, et al.
Diabetes Care (2024) Vol. 48, Iss. Supplement_1, pp. S146-S166
Open Access | Times Cited: 17
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, et al.
Diabetes Care (2024) Vol. 48, Iss. Supplement_1, pp. S128-S145
Open Access | Times Cited: 16
Automated insulin delivery during the first 6 months postpartum (AiDAPT): a prespecified extension study
Tara Lee, Corinne Collett, Simon Bergford, et al.
The Lancet Diabetes & Endocrinology (2025)
Open Access | Times Cited: 2
Subcutaneous weekly semaglutide with automated insulin delivery in type 1 diabetes: a double-blind, randomized, crossover trial
Melissa‐Rosina Pasqua, Michael A. Tsoukas, Alessandra Kobayati, et al.
Nature Medicine (2025)
Open Access | Times Cited: 1
The Artificial Pancreas and Type 1 Diabetes
Munachiso Nwokolo, Roman Hovorka
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 7, pp. 1614-1623
Open Access | Times Cited: 35
Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets
Katrien Benhalima, Kaat Beunen, Sarah E. Siegelaar, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 7, pp. 490-508
Open Access | Times Cited: 35
Real‐world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system
Bruno Grassi, Ana María Gómez, Luís Eduardo Calliari, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 6, pp. 1688-1697
Open Access | Times Cited: 34
Artificial Intelligence and Machine Learning for Improving Glycemic Control in Diabetes: Best Practices, Pitfalls, and Opportunities
Peter G. Jacobs, Pau Herrero, Andrea Facchinetti, et al.
IEEE Reviews in Biomedical Engineering (2023) Vol. 17, pp. 19-41
Open Access | Times Cited: 34
MiniMed 780G Six-Month Use in Children and Adolescents with Type 1 Diabetes: Clinical Targets and Predictors of Optimal Glucose Control
Fortunato Lombardo, Stefano Passanisi, Angela Alibrandi, et al.
Diabetes Technology & Therapeutics (2023) Vol. 25, Iss. 6, pp. 404-413
Closed Access | Times Cited: 32
Digital Technology for Diabetes
Michael S. Hughes, Ananta Addala, Bruce A. Buckingham
New England Journal of Medicine (2023) Vol. 389, Iss. 22, pp. 2076-2086
Closed Access | Times Cited: 30
Association Between Diabetes Technology Use and Glycemic Outcomes in Adults With Type 1 Diabetes Over a Decade
Kagan E. Karakus, Halis Kaan Aktürk, G. Todd Alonso, et al.
Diabetes Care (2023) Vol. 46, Iss. 9, pp. 1646-1651
Closed Access | Times Cited: 27
A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting
Pilar Isabel Beato-Víbora, Ana Chico, Jesús Moreno-Fernández, et al.
Diabetes Care (2023) Vol. 47, Iss. 2, pp. 216-224
Open Access | Times Cited: 26
Practical Aspects and Exercise Safety Benefits of Automated Insulin Delivery Systems in Type 1 Diabetes
Dessi P. Zaharieva, Dale J. Morrison, Barbora Paldus, et al.
Diabetes Spectrum (2023) Vol. 36, Iss. 2, pp. 127-136
Open Access | Times Cited: 22
Automated Insulin Delivery Systems in Children and Adolescents With Type 1 Diabetes: A Systematic Review and Meta-analysis of Outpatient Randomized Controlled Trials
Baoqi Zeng, Le Gao, Qingqing Yang, et al.
Diabetes Care (2023) Vol. 46, Iss. 12, pp. 2300-2307
Open Access | Times Cited: 21
Randomized Trial of Assisted Hybrid Closed-Loop Therapy Versus Sensor-Augmented Pump Therapy in Pregnancy
Sarit Polsky, Elizabeth Buschur, Kathleen Dungan, et al.
Diabetes Technology & Therapeutics (2024) Vol. 26, Iss. 8, pp. 547-555
Closed Access | Times Cited: 14
Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems
Halis Kaan Aktürk, Tadej Battelino, Javier Castañeda, et al.
Diabetes Technology & Therapeutics (2024) Vol. 26, Iss. S3, pp. 102-106
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top